During the past decade, Hamzavi Dermatology conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 23 clinical trials were completed, i.e. on average, 109.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 12 clinical trials were completed. i.e. 171.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hamzavi Dermatology" #1 sponsor was "Galderma R&D" with 6 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Pfizer" with 4 trials sponsored, "Dow Pharmaceutical Sciences" with 3 trials sponsored and "LEO Pharma" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hamzavi Dermatology" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Athenex, Inc." with 1 trials as a collaborator, "Database Integrations, Inc." with 1 trials as a collaborator and "Innovaderm Research Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hamzavi Dermatology" are "Psoriasis" (9 trials), "Acne Vulgaris" (8 trials), "Atopic Dermatitis" (5 trials), "Plaque Psoriasis" (5 trials) and "Actinic Keratosis" (3 trials). Many other conditions were trialed in "Hamzavi Dermatology" in a lesser frequency.

Most popular intervention types in "Hamzavi Dermatology" are "Drug" (40 trials), "Combination Product" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Abrocitinib 200 mg" (2 trials), "BMS-986165" (2 trials), "Baricitinib" (2 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hamzavi Dermatology" are 41 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hamzavi Dermatology". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Hamzavi Dermatology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hamzavi Dermatology, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".